Why Do Doctors Ignore Parasites? The Real Reasons

Doctors don’t ignore parasites on purpose, but the medical system in the U.S. and other high-income countries is genuinely poor at detecting them. A combination of outdated testing, low clinical suspicion, unreliable screening markers, and symptoms that mimic other conditions means parasitic infections routinely get missed or never considered in the first place. If you feel like your concerns about parasites have been brushed off, there are concrete reasons why that happens.

Parasites Are More Common Than Doctors Assume

Many physicians in the U.S. treat parasitic infections as a tropical medicine problem, something relevant to travelers or immigrants but not to the average patient. That assumption is wrong. Toxoplasmosis alone affects roughly 11% of Americans over age six. The CDC has designated several parasitic diseases as “neglected” specifically because they receive too little attention from the U.S. medical community despite significant domestic prevalence.

This perception gap matters because doctors order tests based on what they suspect. If a physician doesn’t consider parasites a realistic possibility for a patient who hasn’t traveled internationally, they simply won’t order the test. The infection never gets looked for, so it never gets found.

Standard Testing Misses a Lot

Even when a doctor does order parasite testing, the most commonly used method, a stool ova and parasite exam under a microscope, has serious limitations. A single stool sample catches only about 75% of infections. That means roughly one in four infected people gets a negative result from a test that was actually ordered correctly. The numbers are similar for detecting specifically harmful organisms, with a single specimen picking up about 74% of pathogenic infections.

The reasons for this are biological. Many parasites don’t shed eggs continuously. Tapeworm eggs, for example, are released intermittently when segments of the worm break apart in the intestine, making detection a matter of timing and luck. The standard recommendation is to collect multiple stool samples on different days, but in practice, many doctors order just one. A single negative result then gets treated as proof that no infection exists.

Microscopy is also operator-dependent. The accuracy of the test depends on the skill and experience of the lab technician examining the slide. In countries where parasitic infections are uncommon, lab staff may have limited experience identifying the wide variety of eggs, cysts, and larvae that can appear in a sample.

Blood Tests Are Unreliable Screeners

When patients push for answers, doctors sometimes point to a standard blood count as evidence against a parasitic infection. The logic is that parasites, particularly worms, cause a specific type of white blood cell called an eosinophil to increase. If your eosinophil count is normal, the reasoning goes, you probably don’t have a parasite.

This logic is flawed. Research on confirmed parasitic infections found that eosinophil counts performed poorly as a screening tool, with sensitivity ranging from just 33% to 73% depending on the parasite and the threshold used. For hookworm infections, about 49% of confirmed cases showed no elevated eosinophils at all. For whipworm, the number was even worse: 54% of infected individuals had completely normal eosinophil levels. A large study of over 1,300 people with confirmed parasitic infections concluded that eosinophilia “should not be used alone for screening” because its predictive value is poor for the most common parasites.

So when a doctor glances at your blood work, sees normal eosinophils, and tells you parasites aren’t the issue, they’re relying on a marker that misses infections roughly half the time.

Symptoms Look Like Other Conditions

Intestinal parasites cause bloating, abdominal pain, diarrhea, constipation, and fatigue. That symptom list is nearly identical to irritable bowel syndrome. Research has found that certain organisms historically considered harmless, like Blastocystis and Dientamoeba fragilis, have been linked to diarrhea-predominant IBS specifically. Some patients carrying these organisms may be diagnosed with IBS and managed with dietary changes or symptom-relief medications while the underlying infection goes unaddressed.

Because IBS is diagnosed by excluding other conditions rather than by a definitive test, it becomes a catch-all label. If a doctor runs basic bloodwork and perhaps a single stool test, gets normal results, and the patient still has chronic gut symptoms, IBS is the most convenient explanation. Parasites fall off the list not because they’ve been ruled out, but because the available tests weren’t sensitive enough to catch them.

Guidelines Don’t Encourage Routine Screening

The CDC’s guidance on parasite testing states that a provider decides which tests to order based on your signs, symptoms, other medical conditions, and travel history. There is no recommendation for routine parasite screening in the general population. This means the decision to test rests entirely on a doctor’s clinical judgment, and that judgment is shaped by training that emphasizes parasites as rare in developed countries.

Medical education in the U.S. covers tropical medicine briefly. Most physicians finish residency having seen very few parasitic infections firsthand. Without that clinical experience, the pattern recognition that drives diagnosis in everyday practice simply isn’t there for parasites. A doctor who has diagnosed hundreds of IBS cases and two parasitic infections will, understandably, reach for the more familiar diagnosis first.

Newer Tests Exist but Aren’t Always Used

Multiplex PCR panels, which test stool samples for dozens of pathogens at once using DNA detection, represent a major improvement over traditional microscopy. These panels detect between 22% and 74% of stool samples as positive, compared to just 8% to 18% using conventional methods. One study of 709 samples found multiple pathogens in 16.4% of cases using a PCR panel versus only 1% with traditional testing. Sensitivity for individual pathogens ranges from about 79% to 100%, far better than microscopy.

These panels also return results within a day, compared to several days for traditional methods. Studies have found that using them reduces unnecessary endoscopies, imaging, antibiotic prescriptions, and hospital stays because clinicians get answers faster and can target treatment appropriately.

Despite these advantages, PCR panels aren’t universally ordered. They cost more upfront, and some insurance plans or hospital systems default to older testing methods. If your doctor orders a stool test and it comes back negative, it’s worth asking which type of test was used. A negative result on a standard microscopy exam carries far less weight than a negative on a multiplex PCR panel.

What You Can Do About It

If you suspect a parasitic infection, being specific in your request helps. Ask for a multiplex gastrointestinal pathogen panel rather than a standard ova and parasite exam. If only microscopy is available, request that multiple samples be collected on separate days, which improves the detection rate. Mention any risk factors clearly: travel history, exposure to untreated water, contact with animals, consumption of raw or undercooked meat, or living in areas with known parasite transmission.

If your primary care doctor is dismissive, an infectious disease specialist or a gastroenterologist with experience in parasitology will have a broader testing toolkit and more familiarity with these infections. Some academic medical centers also have tropical medicine clinics that see domestic parasitic infections regularly.

The frustration of feeling unheard is real, and it has measurable roots: tests that miss infections half the time, blood markers that perform little better than a coin flip, and a medical culture that underestimates how common these infections actually are. The problem isn’t that doctors don’t care. It’s that the default diagnostic pathway for parasites is full of gaps, and closing those gaps often requires patients to advocate for better testing.